Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Gregory G. Schwartz, Philippe Gabríel Steg, Michael J. Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, Jay M. Edelberg, Shaun G. Goodman, Corinne Hanotin, Robert A. Harrington, J. Wouter Jukema, Guillaume Lecorps, Kenneth W. Mahaffey, Angèle Moryusef, Robert C. Pordy, Kirby Quintero, Matthew T. Roe, William J. Sasiela, Jean‐François Tamby, Pierluigi Tricoci, Harvey Douglas White, Andreas Michael Zeiher
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1056/nejmoa1801174
- Published
- Nov 7, 2018
- Venue
- New England Journal of Medicine
- DOI
- 10.1056/nejmoa1801174
- PubMed
- 30403574
- Categories
- Lipoproteins and Cardiovascular Health
- Provenance
- openalex